Glucose counterregulation: prevention and correction of hypoglycemia in humans (Q40883259)

24 September 2017

1 reference

title

Glucose counterregulation: prevention and correction of hypoglycemia in humans (English)

1 reference

24 September 2017

0 references

0 references

1 reference

Cryer PE

1

1 reference

PubMed ID

8447379

24 September 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

American Journal of Physiology

24 September 2017

1 reference

24 September 2017

264

1 reference

24 September 2017

2 Pt 1

1 reference

24 September 2017

E149-55

1 reference

Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans

24 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Role of hepatic autoregulation in defense against hypoglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Glucose Counterregulation in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Influence of Continuous Physiologic Hyperinsulinemia on Glucose Kinetics and Counterregulatory Hormones in Normal and Diabetic Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Banting Lecture: glucose turnover. A key to understanding the pathogenesis of diabetes (indirect effects of insulin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

Role of changes in insulin and glucagon in glucose homeostasis in exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1993.264.2.E149

10.1152/AJPENDO.1993.264.2.E149

21 January 2018

Identifiers

DOI

0 references

PubMed ID

8447379

1 reference

PubMed ID

8447379